University of Pennsylvania
Ultima Vez Modificado: 1 de noviembre del 2006
Do you have a family member with breast or ovarian cancer? Have you been diagnosed with breast cancer before the age of 50? If so, we would like to invite you to participate in a study that will help us to understand how women think about genetic testing for breast/ovarian cancer.
We are looking for women who:
You will be able to complete the study either online or at the University of Pennsylvania . You will also compensated $20 for your time.
If you want to participate or have additional questions, please call Cristin at 215-573-4658 or email firstname.lastname@example.org.
Jun 16, 2011 - The U.S. Food and Drug Administration has approved the Inform Dual ISH test, a genetic test to determine whether women with breast cancer are human epidermal growth factor receptor 2-positive and therefore candidates for trastuzumab (Herceptin).
Jun 16, 2011
Dec 15, 2014